Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

3.77
Delayed Data
As of 4:00pm ET
 -0.275 / -6.80%
Today’s Change
3.72
Today|||52-Week Range
10.98
-12.53%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close4.05
Today’s open4.03
Day’s range3.72 - 4.10
Volume245,059
Average volume (3 months)175,050
Market cap$91.2M
Dividend yield--
Data as of 4:00pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)+46.88%
Earnings growth (this year)-61.76%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
BCLIBrainstorm Cell Ther...-0.06-2.21%
RKDAArcadia Biosciences ...+0.02+1.90%
ARWRArrowhead Pharmaceut...-0.12-6.12%
PRTOProteon Therapeutics...+0.05+2.63%
Data as of 4:00pm ET, 01/19/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$0.00
Annual profit (last year)-$32.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts


Search for Jobs